UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi : Impact Factor & More
eISSN: 1306-133XpISSN: 1306-133X
Share this on:
Key Metrics
CiteScore 
0.3
SJR
Q4Oncology
SNIP
0.09
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | AKAD DOKTORLAR YAYINEVI |
| Language | Turkish |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
The Effect of PET/CT SUV max Value on Anti-EGFR Treatment Response in Lung Adenocarcinoma
- 30 Sep 2025
- International Journal of Hematology and Oncology
Real-World Predictors of Pathologic Response to FLOT in Patients with Resectable Gastric Cancer: A Retrospective Analysis
- 30 Sep 2025
- International Journal of Hematology and Oncology
Surgery and Hypofractionated Radiotherapy Improve Local Control in High-Risk Head and Neck Non-Melanoma Skin Cancer
- 30 Sep 2025
- International Journal of Hematology and Oncology
Clinical Outcomes and Prognostic Factors in AML with Hyperleukocytosis: A Multicenter Real-World Study
- 30 Sep 2025
- International Journal of Hematology and Oncology
Total Body Irradiation as a Component of Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric ALL
- 30 Sep 2025
- International Journal of Hematology and Oncology
Real-World Pathologic Complete Response Rates with Neoadjuvant Pembrolizumab in Stage II–III Triple-Negative Breast Cancer: Impact of Ki-67 Proliferation Index
- 30 Sep 2025
- International Journal of Hematology and Oncology
The Effect of PET/CT SUV max Value on Anti-EGFR Treatment Response in Lung Adenocarcinoma
- 30 Sep 2025
- International Journal of Hematology and Oncology
Real-World Predictors of Pathologic Response to FLOT in Patients with Resectable Gastric Cancer: A Retrospective Analysis
- 30 Sep 2025
- International Journal of Hematology and Oncology
Surgery and Hypofractionated Radiotherapy Improve Local Control in High-Risk Head and Neck Non-Melanoma Skin Cancer
- 30 Sep 2025
- International Journal of Hematology and Oncology
Clinical Outcomes and Prognostic Factors in AML with Hyperleukocytosis: A Multicenter Real-World Study
- 30 Sep 2025
- International Journal of Hematology and Oncology
Total Body Irradiation as a Component of Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric ALL
- 30 Sep 2025
- International Journal of Hematology and Oncology
Real-World Pathologic Complete Response Rates with Neoadjuvant Pembrolizumab in Stage II–III Triple-Negative Breast Cancer: Impact of Ki-67 Proliferation Index
- 30 Sep 2025
- International Journal of Hematology and Oncology
FAQs on UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
How long has UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi been actively publishing? 
What is the publishing frequency of UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi?
How many articles did UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi publish last year?
What is the eISSN & pISSN for UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi?
What is Citescore for UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi?
What is SNIP score for UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi?
What is the SJR for UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi?
Who is the publisher of UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi?
